Article | Open

Improving cartilage phenotype from differentiated pericytes in tunable peptide hydrogels

  • Scientific Reports 7, Article number: 6895 (2017)
  • doi:10.1038/s41598-017-07255-z
  • Download Citation
Received:
Accepted:
Published online:

Abstract

Differentiation of stem cells to chondrocytes in vitro usually results in a heterogeneous phenotype. This is evident in the often detected over expression of type X collagen which, in hyaline cartilage structure is not characteristic of the mid-zone but of the deep-zone ossifying tissue. Methods to better match cartilage developed in vitro to characteristic in vivo features are therefore highly desirable in regenerative medicine. This study compares phenotype characteristics between pericytes, obtained from human adipose tissue, differentiated using diphenylalanine/serine (F2/S) peptide hydrogels with the more widely used chemical induced method for chondrogenesis. Significantly higher levels of type II collagen were noted when pericytes undergo chondrogenesis in the hydrogel in the absence of induction media. There is also a balanced expression of collagen relative to aggrecan production, a feature which was biased toward collagen production when cells were cultured with induction media. Lastly, metabolic profiles of each system show considerable overlap between both differentiation methods but subtle differences which potentially give rise to their resultant phenotype can be ascertained. The study highlights how material and chemical alterations in the cellular microenvironment have wide ranging effects on resultant tissue type.

Introduction

Induction of mesenchymal stem cells (MSCs) to undergo chondrogenesis requires the cells to have strong cell-cell interactions and that they maintain a spherical morphology. The added use of growth factors in culture media such as transforming growth factors (TGFs) and bone morphogenetic proteins (BMPs) have also been shown to induce chondrogenesis1, 2. However, a common observation when inducing MSCs to form chondrocytes in vitro is the expression of type X collagen by the cells3,4,5,6. Typically, type X collagen is not expressed in the mid-zone of hyaline cartilage and is characteristic of chondrocytes undergoing hypertrophy and endochondral ossification in the deep-zone region of the tissue7, 8 suggesting that in vitro, the cells differentiate along a mixed phenotypic lineage. Over exposure to compounds such as TGF-β1 is thought to be responsible for increased type X expression3, 6 and, as such, biomaterial systems which are able to influence phenotypic expression are highly desirable as a replacement for chemically induced differentiation.

The use of stem cells for engineering cartilage is of particular interest as they facilitate continual development from chondroblasts to terminal differentiation (hypertrophic chondrocytes), a characteristic which is not observed with the use of chondrocytes9. Also, induced differentiation of stem cells is able to provide an abundant source of chondrocytes to compensate for the naturally low cell numbers found in cartilage tissue. Cartilage is an avascular tissue type and naturally occuring cell populations are low. To collect and culture mature chondrocytes up to required population numbers is time consuming and costly. For this reason, prefered approaches for engineering cartilage have been to differentiate stem cells in vitro which can then be used in vivo. Pericytes, or perivascular stem cells, are sourced from the vasculature, inclusive of adipose tissue10,11,12. Thus, they are able to meet the much needed demand of a highly abundant multipotent cell type and are well placed for use in cartilage tissue engineering.

Tuning of material mechanical properties (stiffness) is an effective means of targeting a range of MSC fates, inclusive of chondrogenesis13,14,15. Supramolecular gels have shown enormous potential as model biomaterials to meet this particular challenge16,17,18,19. There have been major successes in the application of self-assembled peptide based materials as instructive matrices for stem cell growth, where the emphasis has been on the inclusion of biochemical signals, usually comprising matrix protein specific peptidic motifs18. There has also been focus on chemical approaches to control gel stiffness, either via redesign of building blocks or chemical crosslinking20. A number of breakthroughs have shown that stem cells’ growth and differentiation, in addition to biochemical signals, are highly sensitive to physical stimuli presented by their immediate environment21, 22. Specifically, mechanical21 (i.e. gel stiffness) and structural/topographical factors23 of the cell-contacting matrix play crucial roles that have, in some cases, been shown to be more powerful than soluble biochemical signals24.

Previously, we had shown that pericytes cultured in supramolecular peptide hydrogels were able to undergo differentiation into a number of cell lineages when the hydrogels were tuned to various stiffnesses25. In this study, an interesting find was the differentiation of pericytes along the chondrogenic lineage when cells were cultured in 13 kPa hydrogel, contrary to the previously observed myogenic development in other biomaterials with similar stiffnesses24, 26. The distinction of which can be explained by the use of a nanofiber structured hydrogel which the cells interact differently with compared to crosslinked materials25.

As this was an unusual observation for cellular differentiation in mechanically tuned substrates, where cell behaviour is contradictory to the norm, this study aimed to ascertain the properties of chondrocytes that develop in the Fmoc-F2/S hydrogels. We do this by further investigating the chondrogenic induction of pericytes, if Fmoc-F2/S hydrogels are able to sustain development in the longer term and whether the effective cellular development can be enhanced with the aid of chondrogenic induction media.

Results

Fmoc-F2/S hydrogels act as biomaterial substrate to promote chondrogenesis of pericytes

We recently reported on the use of co-assembled hydrogels of the well-known gelator fluorenylmethoxycarbonyl (Fmoc)-diphenylalanine (F2)27, 28 and surfactant-like Fmoc-serine (Fmoc-S) to produce cyto-compatible core/shell nanofibers that may be crosslinked upon exposure to cell culture media, resulting in gelation (Fig. 1A and B)29. The mechanical properties of the Fmoc-F2/S hydrogels were tuned by careful control of the peptide concentration in the pre-gel liquid before initiating cross linking with introduction to culture media, allowing gelation to occur as published previously25. The supramolecular hydrogels were therefore created using peptide concentrations that allow the formation of gels with moduli similar to that reported for chondrons30, 31. Oscillatory rheology of the hydrogel shows that the gels possess elastic moduli of 15.5 kPa (Fig. 1D). The G′, elastic modulus, exceeds the viscous modulus G″, signifying that the hydrogel is an elastic material. The nanoscale features and hydrophilic chemistry presented by Fmoc-S on the surface allows nanoscale hydrogel fibres to adsorb proteins which enable indirect contact with cell surface receptors facilitating the cell-material interaction needed to interpret biomaterial qualities (Fig. 1C).

Figure 1
Figure 1

Self-assembly of two-component gelators. (A) Schematic presentations of the building blocks, gelator Fmoc-F2, surfactant Fmoc-S and surfactant coated nano fiber Fmoc-F2/S. (B) Macroscopic image for gel in culture media. (C) TEM image of hydrogel showing fibrous morphology. (D) Oscillatory rheology of the gels showing elastic moduli of 15.5 kPa.

Promotion of chondrogenic development in vitro generally requires that cells are cultured within a three dimensional construct in order to maintain a typical rounded morphology and eliminating the dedifferentiation effects of monolayer culture32,33,34. The formation of aggregates in culture is of particular advantage as it has been shown to promote chondrogenic development in stem cells35, 36. Pericytes cultured within the 15.5 kPa Fmoc-F2/S hydrogels were observed to have good viability with cells forming small clusters (aggregates) over time (Fig. 2A). Pericyte differentiation was assessed by monitoring gene expression levels of RUNX-2, SOX-9 and type II collagen after 1 week which showed increased expression levels of all three genes compared to the negative control with SOX-9 and type II collagen in particular showing a statistically significant increase (Fig. 2B).

Figure 2
Figure 2

(A) Human adipose derived pericyte cultured within Fmoc-F2/S hydrogels. Cells were encapsulated in F2/S hydrogels and maintained in unsupplemented basal media for up to 1 week. Cells were checked for viability by fluorescence detection of Syto 10 (green) for live cells and ethidium homodimer-1 (red) for dead cells after 1, 3 and 7 days. (B) QRT-PCR analysis for gene expression of pericyte cells cultured within 15.5 kPa Fmoc-F2/S hydrogels. Cells were assessed for the production of chondrogenic biomarkers RUNX-2, SOX-9 & type II collagen (COL2A1) after one week in culture. (C & D) Confocal microscopy images of immunofluorescently stained F2/S hydrogels cultured with pericytes for 28 days. Pericytes were checked for chondrogenic development by staining for aggrecan production (C) and type II collagen (D) both ascertained through green fluorescence. Cell populations are indicated by staining the cell nucleus with DAPI (blue). The images are mosaics of a 3 × 3 tile scan, each acquired from random positions of the hydrogel. Scale bar in A is 100 µm, in C & D is 50 µm. In B, Error bars denote the standard error where p < 0.05 as calculated using unpaired student t-test.

Cells were then cultured over a longer term (5 weeks) within the Fmoc-F2/S substrate and were subsequently immunofluorescently stained for type II collagen and aggrecan production. Confocal microscopy imaging demonstrated the presence of both proteins indicating successful differentiation of the pericytes into chondrocytes (Fig. 2C and D).

Fmoc-F2/S hydrogel promotes lessens formation of type X collagen while balancing aggrecan and type II collagen ratios

Phenotypic characteristics of differentiated pericytes were monitored by focusing on the relative expression levels of type II collagen, aggrecan and type X collagen after long-term culture (35 days). Comparisons were carried out using pericytes cultured in the 15.5 kPa Fmoc-F2/S gels in the presence (+) and absence (−) of chondrogenic induction medium. In addition, pericytes were also cultured in alginate hydrogels with chondrogenic induction medium in order to make a comparison with a conventionally used hydrogel system for chondrogenesis that is also used in MACI37,38,39,40,41. It is noteworthy to mention that many studies which use alginate for chondrogenesis of MSCs, culture the cells using low serum (1% FBS) concentrations. As chondrogenesis was originally observed in Fmoc-F2/S substrates using standard basal media composition (10% FBS), this study retains the conditions in which the original observation was made for both alginate and Fmoc-F2/S.

Gene expression profiles of pericytes showed an increase in all cartilage biomarkers over 1 week after which trends held steady up to 35 days indicating differentiation of pericytes. Marker expression levels from pericytes in both Fmoc-F2/S+ and Fmoc-F2/S− hydrogels were distinctly higher than those in alginate. The Fmoc-F2/S+ showed the highest production of SOX-9, type II collagen and type X collagen respectively (Fig. 3). Assessment of collagen and glycosaminoglycan production relative to each other showed that the outcome of this was dependent on which culture system was used. Type II collagen production was highest in Fmoc-F2/S+, having on average 2.6 fold higher concentrations compared to aggrecan (Fig. 4A). Aggrecan content was largest when alginate was used (Fig. 4A). Pericytes cultured in Fmoc-F2/S− hydrogels exhibited an overall balance between type II collagen and aggrecan expression (0.89x, Fig. 4A).

Figure 3
Figure 3

Quantitative PCR analysis assessing chondrocyte development of pericytes encapsulated in Fmoc-F2/S hydrogels with (+), without (−) chondrogenic induction and in alginate hydrogels (ALG) also cultured with chondrogenic induction media. Cells were assessed for gene expression of the cartilage biomarkers SOX-9 (A), type II collagen (B), aggrecan (C) and type X collagen (D) up to 35 days in culture. Expression levels of all four biomarker were observed as elevated for all culture systems with the highest expression levels noted for pericytes cultured in Fmoc-F2/S hydrogels. Gene expression was compared against pericytes cultured on glass cover slips (undifferentiated on planar substrate) as a negative control. Error bars are standard error of the mean; * indicate significant difference between groups as determined by one-way ANOVA followed by Bonferroni post hoc test where p < 0.05; n = 4.

Figure 4
Figure 4

Comparison of chondrocyte expression of pericyte cells differentiated over a 5 week period using 15.5 kPa Fmoc-F2/S hydrogels in the presence (+) and absence (−) of chondrogenic induction media. Cells were also differentiated using alginate hydrogels and chondrogenic induction media. (A) Expression of type II collagen relative to aggrecan showed higher type II collagen transcription for cells cultured in Fmoc-F2/S + hydrogels. (B) Expression of type II collagen relative to type X collagen. Gene expression was compared against pericytes cultured on glass cover slips (undifferentiated on planar substrate) as a negative control. Error bars are standard error of the mean; * indicate significant difference between groups as determined by one-way ANOVA followed by Bonferroni post hoc test where p < 0.05; n = 4.

Over expression of type X collagen compared to type II is known to be prevalent in most in vitro systems that differentiate stem cells into chondrocytes. This phenomenon is thought to be due to the culture system having an over exposure to transforming growth factor β1 (TGF-β1)3, 6 and also because of the use of ascorbic acid42,43,44, both of which are typically used in formulating chondrogenic induction medium. While Fmoc-F2/S+ and alginate produced the collagen II/collagen X ratio with greater collagen X weighting; it was seen, however, that F2/S−, which is absent of the tailored medium, produced the desired ratio with greater collagen II weighting (Fig. 4B), highlighting the influence of the supplemented medium on resultant cellular differentiation.

Chondrocyte metabolome highlights pathways that are causal of phenotypic differences

Metabolomics data were generated using high-resolution LC-MS analysis of denatured cell extracts of pericytes cultured in the Fmoc-F2/S+/− hydrogel systems. Comparisons between these two systems allowed identification of cell processes that are affected by the presence of induction medium and which subsequently lead to differences in phenotypic expression. A generalised overview of the metabolome using hierarchical cluster analysis showed that, on the whole, the metabolite profiles of Fmoc-F2/S+/− systems, although distinct from the undifferentiated control set, were similar to each other with slightly higher metabolite abundances detected on the Fmoc-F2/S+ substrate (Fig. 5A). Detected metabolite masses were mapped to known pathways to ascertain which areas of metabolism were most differentiated from the control set. The pathways showing the most significant change were those involved in amino acid metabolism and energy generating processes such as the TCA cycle (Fig. 5B). Of these, the most changed significantly were metabolites involved in arginine and proline metabolism. A pathway which contributed to the development of collagen and the synthesis of polyamines. Polyamines are known to play an important role in proliferation and differentiation45, 46, and in particular, development of chondrocytes47.

Figure 5
Figure 5

Analysis of metabolite masses detected from pericyte cell extracts undergoing chondrogenesis (n ≥ 12). (A) Hierarchical cluster analysis of metabolic MS masses detected using LC-MS for pericytes cultured on planar substrates (undifferentiated) and cultured in Fmoc-F2/S in the presence or absence of chondrogenic induction media 35 days. (B) Metabolites were mapped to metabolic pathways to ascertain which cell processes are significantly changed from the control. (C) Comparisons between Fmoc-F2/S− and Fmoc-F2/S+ isolate metabolite masses that differ between the two by more than two fold (inset) giving insight into processes that lead to the altered chondrocyte phenotype between Fmoc-F2/S− and Fmoc-F2/S+ Pathways marked with Ɨ were observed to be significantly different from undifferentiated cells but not between Fmoc-F2/S− and Fmoc-F2/S+ suggesting influence during chondrogenesis but do not contribute to the observed differences in chondrocyte phenotype.

Closer inspection between Fmoc-F2/S+ and Fmoc-F2/S− reveal pockets of distinction between the two. These potentially highlight metabolic processes that ultimately result in the phenotypic differences observed in Fig. 4.Sample sets were compared against each other and a nominal threshold of 2 was set to isolate metabolites considered as distinct from one another. From the total population (734), 23.4% of these were considered to be of interest. When mapped to metabolic processes, the pathways that had the greatest number of hits and therefore most contrasting turnover were centred mainly in amino acid metabolism. Observed differences between Fmoc-F2/S− and Fmoc-F2/S+ therefore indicate differences in the protein make up between both systems. Pathways such as tyrosine metabolism and arginine & proline metabolism, however, showed no significant change between both systems suggesting that they are requisite for chondrocyte development but do not necessarily play a role in the observed shifts in phenotype between Fmoc-F2/S− and Fmoc−F2/S+ (Fig. 5C).

Significantly changed pathways involved in energy generation, such as the TCA cycle, although different from undifferentiated cells showed no discernible difference between Fmoc-F2/S- and Fmoc-F2/S+ as cells in both substrates are considered to be similarly active.

Discussion

The use of the biomaterial alone not only instigates pericytes to undergo chondrogenesis but the cells are also able to sustain continual development as observed through the constant production of the chondrogenic markers over a longer time in culture. The use of induction medium with the hydrogels causes a phenotypical imbalance, most notably with the production of collagen. No difference between the two systems (with and without induction media) are noted with regards to aggrecan production, suggesting that induction medium is better tailored to collagen development.

The type of collagen formed, however, is affected by the induction media as generally higher type X collagen content is observed in these systems over type II collagen. This correlates with the gene expression profiles observed in Fig. 2 where initial chondrogenesis of pericytes is assessed. In the absence of the induction media, RUNX-2 expression levels is lowered compared to SOX-9. Subsequently, formation of type X collagen, which is pre-empted by RUNX-2, is lowered and we observe higher type II collagen content. Relative levels of the gene markers in alginate were significantly lower than the Fmoc-F2/S hydrogels which may be due to the difference in the cell type used, as opposed to MSCs for example, as well as the deviation from the typical use of low serum concentrations. Notwithstanding, comparative production of chondrogenic markers in alginate show that the use of induction media for differentiation also gives a higher proportion of type X collagen formation over type II collagen. Levels that are comparable with Fmoc-F2/S+ (Fig. 4B). Typically observed in vitro, type X collagen imbalance suggests greater population of hypertrophic chondrocytes5, 6, 48, thought to occur due to the initiation of some osteogenic activity3, 6. The detection of type X collagen in the Fmoc-F2/S- system however, indicates that its production is not completely eliminated but significantly reduced when chemical induction is avoided.

The interplay between collagen and glycosaminoglycan content is noteworthy as the distribution of one relative to the other in native cartilage plays an important role in the functional output of the tissue as a whole. The zonal structure of native hyaline cartilage, shows increased abundance in glycosaminoglycan content moving from the articular surface through the superficial, mid and deep zones where there is the greatest resistance to compressive loading8, 49, 50. Therefore, in order to impart better functionality when healing damaged cartilage tissue, the implication of balancing the abundance of type II collagen and aggrecan when developing cartilage tissue in vitro through mechanical and chemical substrate design is of particular importance, as it should best match the required structure of the lost tissue. The balance achieved with using Fmoc-F2/S− (Fig. 4A) allows for potential formation of a tissue type that is not overly inflexible due to higher collagen content than is observed when including induction medium.

While the findings from the metabolomics study are preliminary, they demonstrate correlation of cell behaviour with their microenvironment and a means of acutely discriminating between potential sub-phenotypes of a particular cell type. That is, distinguishing between finer details that cannot be simply reflected in ‘positive’ detection of specific markers. This however requires further experimental design and implementation beyond the scope of this study.

Methods

Formation of the Fmoc hydrogels

Pre gelation mixture was prepared by mixing diphenylalanine (F2) and serine (S) powders (both capped at the N-terminal with fluorenylmethoxycarbonyl (Fmoc)) in 14 mL glass vials and suspending the powders to a 30 mM peptide concentration in sterile/distilled H2O. 0.5 M NaOH was added dropwise until the powders were fully dissolved. The vial was mixed with alternated vortexing and sonication and then 0.5 M HCl was added until the desired pH was reached (7.5–8.0). Prior to use, Fmoc-F2/S pre gelation mixtures were sterilized under UV light for 45 min.

Alginate solution

A 1.2% (w/v) alginate solution was made by dissolving 0.360 g of alginate powder (Sigma) slowly in 30 ml of phosphate buffered saline containing a magnetic stirrer. The solution was then autoclaved at 120 °C for 20 minutes.

Rheology

To assess the mechanical properties of the hydrogels, dynamic frequency sweep experiments were carried out on a strain-controlled rheometer (Kinexus rotational rheometer from Malvern) using a parallel-plate geometry (20 mm) with a 0.50 mm gap. An integrated temperature controller was used to maintain the temperature of the sample stage at 25 °C. Precautions were taken to minimize solvent evaporation and to keep the sample hydrated: a solvent trap was used and the atmosphere within was kept saturated. To ensure the measurements were made in the linear viscoelastic regime, an amplitude sweep was performed and the results showed no variation in elastic modulus (G′) and viscous modulus (G″) up to a strain of 1%. The dynamic modulus of the hydrogel was measured as a frequency function, where the frequency sweeps were carried out between 1 and 100 Hz. The measurements were repeated at least three times to ensure reproducibility.

Transmission electron microscopy (TEM)

Carbon-coated copper grids (No. 400) were glow discharged for 5 s and placed shiny side down on the surface of the hydrogel for less than 5 s. Excess sample was removed by blotting with a filter paper and then 10 mL of negative stain (Nanovan: 1% aqueous methylamine vanadate, obtained from Nanoprobes) was placed on the top of the sample on the grid and allowed to dry for 10 mins. The dried specimens were then imaged using a LEO 912 energy filtering transmission electron microscope operating at 120 kV fitted with a 14 bit/2 K Proscan CCD camera. Fiber diameters were measured using ImageJ software version v1.43 u.

Pericyte isolation

Adipose tissue was collected with prior informed and written consent from healthy adult volunteers (n = 3) undergoing cosmetic lipectomy procedures. Permission for tissue collection and subsequent experimental protocols were granted and carried out in accordance with stated guidelines by the South East Scotland Research Ethics Committees (SESREC 10/S1103/45) in Edinburgh.

Pericytes were isolated from adipose tissue from adult donors undergoing cosmetic liposuction by Flow Activated Cell Sorting (FACS) using a FACS Aria II (BD Biosciences) based on our established protocols10 and is summarised below.

Adipose tissue was enzymatically digested with type II collagenase (1 mg/ml, Sigma-Aldrich) for 30 mins in a shaking waterbath at 37 °C to obtain the Stromal Vascular Fraction (SVF). SVF was then stained with the following antibodies; CD146-Alexa647 (1:100, AbD Serotec, Raleigh, NC), CD45 APC-cy7, CD31-FITC, and CD34-PE (1:100, all from BD Biosciences, San Jose, CA). Pericytes were sorted to homogeneity based on the following phenotype CD146+, CD45−, CD34− and CD31−. Immediately following FACS, pericytes were seeded onto 0.1% gelatin coated wells at a density of 20,000 cells/cm2 in EGM-2 media (Lonza) in a humidified incubator with 5% CO2 at 37 °C. When confluent, cells were detached from the cultureware using 0.25% trypsin and split at a ratio of 1:6 and cultured in DMEM + 20% FCS for all subsequent passages. Media was changed 3 times per week. Purity of pericyte cultures was confirmed by flow cytometry (Supplementary data, Figure S1).

Cell Culture and Reagents

Pericytes were tripsinised from the culture well flasks, pelleted by centrifugation and resuspended in either the Fmoc-F2/S or the alginate solution.

Cell laden alginate beads were made by pipetting 300 µL of the alginate solution into a 100 mM calcium chloride solution. They were allowed to cure at room temperature for 5 minutes before removing the calcium chloride solution. Hydrogels were then washed twice with PBS solution and 500 μl of culture media added to each well.

300 µL of the Fmoc-F2/S cells suspension was dispensed into 24 well culture plates containing 500 μl of culture media. Culture plates were incubated under humidified atmosphere of 5% CO2 at 37 °C for approximately 1 hr to allow the Fmoc-F2/S hydrogels to fully cure. Following this, the media in both the peptide and alginate hydrogels were changed every 24 hours in the first two days of preparation and every twice weekly after that.

Chondrogenic differentiation in one subset of the Fmoc-F2/S and in alginate was induced using DMEM containing 10% FBS, insulin (6.25 μg/ml), dexamethasone (10 nM), ascorbate-2-phosphate (50 nM), transforming growth factor (TGF-β1, 10 ng/ml) and sodium pyruvate (110 μg/ml).

Cell viability

Culture media surrounding the biomaterials were aspirated to waste and washed once with warm PBS solution. A working solution containing both Syto 10 and ethidium homodimer-2 dyes was made in PBS (1:500 v/v). 500 µL of the dye solution was added to the hydrogels and the samples incubated in the dark at room temperature for 15 minutes.

Following this, the hydrogels were then fixed at room temperature with 4% formaldehyde solution for at least 15 minutes before viewing under a microscope.

Immunofluorescence cell staining

After 28 days in culture (unless otherwise stated), the cells were washed once in PBS and fixed with 10% formaldehyde at 37 °C for 15 min. When fixed, the samples were permeabilised using a buffer solution (10.3 g sucrose, 0.292 g NaCl, 0.06 g MgCl2, 0.476 g Hepes buffer, 0.5 ml Triton X, in 100 ml water, pH 7.2) at 4 °C for 5 min. The samples were then incubated at 37 °C for 5 min in 1% BSA/PBS, followed by the addition of the primary antibody (1:50 in 1% BSA/PBS, monoclonal anti-human collagen type II and aggrecan raised in mouse (IgG1), Santa Cruz Biotechnology Inc) for 1 h (37 °C). The samples were then washed in 0.5% Tween 20/PBS (5 min, ×3). A secondary, biotin-conjugated antibody (1:50 in 1% BSA/PBS, monoclonal anti-mouse (IgG), Vector Laboratories, Peterborough, UK) was added for 1 h (37 °C) followed by washing. A FITC conjugated streptavidin third layer was added (1:50 in 1% BSA/ PBS, Vector Laboratories, Peterborough, UK) at 4 °C for 30 min, and given a final wash.

QRT-PCR analysis

RNA extractions from cells cultured on hydrogel biomaterials were done using the Trizol extraction reagent (Invitrogen). Cells cultured for on culture well plastic had RNA retrieved using RNeasy micro kit (Qiagen), both protocols were carried out as per manufacturer’s instructions. Reverse transcription to obtain cDNA was done using Quantitech reverse transcription kit (Qiagen) for all samples, also according to the manufacturer’s protocol. Cells were cultured and harvested at time points 1hr, 1, 3, 7, 14, 28 and 35 days in culture.

Amplification by qRT-PCR was done using human specific primers (Eurofins MWG Operon) detailed in Table 1. PCR was carried out using a 7500 Real time PCR system & software (Applied Biosystems). Samples had a total reaction volume of 20 µL containing 2 µL of diluted cDNA, each reverse and forward primer at a final concentration of 100 µM and analysed using SYBR green chemistry (Qiagen). For PCR amplification samples were held at 50 °C for 2 minutes then 95 °C for 10 min then amplified using 95 °C for 15 s and 60 °C for 1 min for 40 cycles. The specificity of the PCR amplification was checked with a heat dissociation curve (measured between 60–95 °C) done subsequent to the final PCR cycle. Gene expression levels were standardised using GAPDH as an internal control. Quantification analysis was performed using the comparative ΔΔCt method51 and gene expression expressed as fold change relative to the control sample.

Table 1: Real time PCR primers used to quantify mRNA expression from human genes.

Samples were assayed in quadruplicate and gene expression was expressed as mean ± SEM.

Metabolomic analysis

Metabolite extraction from cells cultured on hydrogels and control samples for 1 week was done using ice cold chloroform:methanol:water (1:3:1,v/v) on a shaker for 1 h maintained at 4 °C. Samples were centrifuged and 10 μL of the supernatant injected on to the LC-MS system.

The LC separation was carried out using hydrophilic interaction chromatography with a ZIC-HILIC 150 mm × 4.6 mm, 5 μm column (Merck Sequant), operated by an UltiMate liquid chromatography system (Dionex, Camberley, Surrey). The LC mobile phase was run with 0.1% formic acid in water (A) and 0.08% formic acid in acetonitrile (B). The mobile phase was run at a linear gradient for 30 minutes from 20–80% A, maintained at 5% A for 10 minutes and then re-equilibrated to 20% A. Mass spectrometric detection was performed using an Orbitrap Exactive (Thermo Fisher Scientific, Hemel Hempstead, U.K.) within the mass range m/z 70–1400 in polarity switching mode.

Chromatographic peak selection and metabolite identification were done using Ideom/MzMatch excel interface52, 53 and measured peak intensities by LC-MS were normalised against protein content as measured using the Bradford assay as detailed previously54. Metabolite identification was done using a set of known standards to define mass and chromatographic retention times. Putative metabolites were also identified on this basis using predicted retention times as described by Creek et al.55.

Statistical Analysis

Analysis of variance (ANOVA) and Bonferroni post hoc tests were performed using GraphPad prism software to compare more than two study groups. Statistical significance is noted where the calculated p value is less than 0.05 using four biological replicates unless otherwise stated.

Multivariate analysis of the LC-MS data and metabolite pathway mapping were done using Metaboanalyst 2.056.

Data availability

Raw data generated from this study is available from http://dx.doi.org/10.5525/gla.researchdata.344.

Additional Information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Muraglia, A. et al. Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells. Journal of Cell Science 116, 2949–2955, doi:10.1242/jcs.00527 (2003).

  2. 2.

    Sekiya, I., Vuoristo, J. T., Larson, B. L. & Prockop, D. J. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proceedings of the National Academy of Sciences of the United States of America 99, 4397–4402, doi:10.1073/pnas.052716199 (2002).

  3. 3.

    Cooke, M. E. et al. Structured three-dimensional co-culture of mesenchymal stem cells with chondrocytes promotes chondrogenic differentiation without hypertrophy. Osteoarthritis and Cartilage 19, 1210–1218, doi:10.1016/j.joca.2011.07.005 (2011).

  4. 4.

    Cui, X., Hasegawa, A., Lotz, M. & D’Lima, D. Structured three-dimensional co-culture of mesenchymal stem cells with meniscus cells promotes meniscal phenotype without hypertrophy. Biotechnology and Bioengineering 109, 2369–2380, doi:10.1002/bit.24495 (2012).

  5. 5.

    Karlsson, C. et al. Differentiation of human mesenchymal stem cells and articular chondrocytes: Analysis of chondrogenic potential and expression pattern of differentiation-related transcription factors. Journal of Orthopaedic Research 25, 152–163, doi:10.1002/jor.20287 (2007).

  6. 6.

    Perrier, E. et al. Analysis of collagen expression during chondrogenic induction of human bone marrow mesenchymal stem cells. Biotechnology Letters 33, 2091–2101, doi:10.1007/s10529-011-0653-1 (2011).

  7. 7.

    Hunziker, E. B., Michel, M. & Studer, D. Ultrastructure of adult human articular cartilage matrix after cryotechnical processing. Microscopy Research and Technique 37, 271–284, doi:10.1002/(sici)1097-0029 (1997).

  8. 8.

    Responte, D. J., Natoli, R. M. & Athanasiou, K. A. Collagens of Articular Cartilage: Structure, Function, and Importance in Tissue Engineering. Critical Reviews in Biomedical Engineering 35 (2007).

  9. 9.

    Vonschroeder, H. P., Kwan, M., Amiel, D. & Coutts, R. D. The use of polylactic acid matrix and periosteal grafts for the reconstruction of rabbit knee articular defects. Journal of Biomedical Materials Research 25, 329–339, doi:10.1002/jbm.820250305 (1991).

  10. 10.

    Corselli, M. et al. Identification of perivascular mesenchymal stromal/stem cells by flow cytometry. Cytometry. Part A: the journal of the International Society for Analytical Cytology 83, 714–720, doi:10.1002/cyto.a.22313 (2013).

  11. 11.

    Crisan, M. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301–313, doi:10.1016/j.stem.2008.07.003 (2008).

  12. 12.

    West, C. C. et al. Prospective purification of perivascular presumptive mesenchymal stem cells from human adipose tissue: process optimization and cell population metrics across a large cohort of diverse demographics. Stem Cell Research & Therapy 7, doi:10.1186/s13287-016-0302-7 (2016).

  13. 13.

    Allen, J. L., Cooke, M. E. & Alliston, T. ECM stiffness primes the TGF beta pathway to promote chondrocyte differentiation. Molecular Biology of the Cell 23, 3731–3742, doi:10.1091/mbc.E12-03-0172 (2012).

  14. 14.

    Discher, D. E., Janmey, P. & Wang, Y. L. Tissue cells feel and respond to the stiffness of their substrate. Science 310, doi:10.1126/science.1116995 (2005).

  15. 15.

    Engler, A. J. et al. Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. Journal of Cell Biology 166, 877–887, doi:10.1083/jcb.200405004 (2004).

  16. 16.

    Banwell, E. F. et al. Rational design and application of responsive alpha-helical peptide hydrogels. Nature Materials 8, 596–600, doi:10.1038/nmat2479 (2009).

  17. 17.

    Collier, J. H. Modular self-assembling biomaterials for directing cellular responses. Soft Matter 4, doi:10.1039/b805563g (2008).

  18. 18.

    Silva, G. A. et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 303, 1352–1355, doi:10.1126/science.1093783 (2004).

  19. 19.

    Webber, M. J., Appel, E. A., Meijer, E. W. & Langer, R. Supramolecular biomaterials. Nature Materials 15, 13–26, doi:10.1038/nmat4474 (2016).

  20. 20.

    Pashuck, E. T., Cui, H. & Stupp, S. I. Tuning Supramolecular Rigidity of Peptide Fibers through Molecular Structure. Journal of the American Chemical Society 132, 6041–6046, doi:10.1021/ja908560n (2010).

  21. 21.

    Discher, D. E., Mooney, D. J. & Zandstra, P. W. Growth Factors, Matrices, and Forces Combine and Control Stem Cells. Science 324, 1673–1677, doi:10.1126/science.1171643 (2009).

  22. 22.

    Mei, Y. et al. Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nature Materials 9, 768–778, doi:10.1038/nmat2812 (2010).

  23. 23.

    Dalby, M. J. et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nature Materials 6, 997–1003, doi:10.1038/nmat2013 (2007).

  24. 24.

    Engler, A. J., Sen, S., Sweeney, H. L. & Discher, D. E. Matrix elasticity directs stem cell lineage specification. Cell 126, 677–689, doi:10.1016/j.cell.2006.06.044 (2006).

  25. 25.

    Alakpa, E. V. et al. Tuneable supramolecular hydrogels for selection of lineage guiding metabolites in stem cell cultures. Chem 1, 298–319, doi:10.1016/j.chempr.2016.07.001 (2016).

  26. 26.

    Gilbert, P. M. et al. Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-Renewal in Culture. Science 329, 1078–1081, doi:10.1126/science.1191035 (2010).

  27. 27.

    Jayawarna, V. et al. Nanostructured hydrogels for three-dimensional cell culture through self-assembly of fluorenylmethoxycarbonyl-dipeptides. Advanced Materials 18, 611, doi:10.1002/adma.200501522 (2006).

  28. 28.

    Mahler, A., Reches, M., Rechter, M., Cohen, S. & Gazit, E. Rigid, self-assembled hydrogel composed of a modified aromatic dipeptide. Advanced Materials 18, 1365, doi:10.1002/adma.200501765 (2006).

  29. 29.

    Jayawarna, V. et al. Introducing chemical functionality in Fmoc-peptide gels for cell culture. Acta Biomaterialia 5, 934–943, doi:10.1016/j.actbio.2009.01.006 (2009).

  30. 30.

    Nguyen, B. V. et al. Biomechanical properties of single chondrocytes and chondrons determined by micromanipulation and finite-element modelling. Journal of the Royal Society Interface 7, doi:10.1098/rsif.2010.0207 (2010).

  31. 31.

    Ofek, G. & Athanasiou, K. A. Micromechanical properties of chondrocytes and chondrons: Relevance to articular cartilage tissue engineering. Journal of Mechanics of Materials and Structures 2, doi:10.2140/jomms.2007.2.1059 (2007).

  32. 32.

    Caron, M. M. J. et al. Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures. Osteoarthritis and Cartilage 20, 1170–1178, doi:10.1016/j.joca.2012.06.016 (2012).

  33. 33.

    Darling, E. M. et al. Mechanical Properties and Gene Expression of Chondrocytes on Micropatterned Substrates Following Dedifferentiation in Monolayer. Cellular and Molecular Bioengineering 2, 395–404, doi:10.1007/s12195-009-0077-3 (2009).

  34. 34.

    Matsumoto, E., Furumatsu, T., Kanazawa, T., Tamura, M. & Ozaki, T. ROCK inhibitor prevents the dedifferentiation of human articular chondrocytes. Biochemical and Biophysical Research Communications 420, 124–129, doi:10.1016/j.bbrc.2012.02.127 (2012).

  35. 35.

    Maleski, M. P. & Knudson, C. B. Hyaluronan-mediated aggregation of limb bud mesenchyme and mesenchymal condensation during chondrogenesis. Experimental Cell Research 225, 55–66, doi:10.1006/excr.1996.0156 (1996).

  36. 36.

    Tachetti, C. et al. Cell condensation in chondrogenic differentiation. Experimental Cell Research 200, 8 (1992).

  37. 37.

    Bosnakovski, D. et al. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: Influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnology and Bioengineering 93, 1152–1163, doi:10.1002/bit.20828 (2006).

  38. 38.

    Coates, E. E., Riggin, C. N. & Fisher, J. P. Photocrosslinked alginate with hyaluronic acid hydrogels as vehicles for mesenchymal stem cell encapsulation and chondrogenesis. Journal of Biomedical Materials Research Part A 101A, 1962–1970, doi:10.1002/jbm.a.34499 (2013).

  39. 39.

    Ma, K., Titan, A. L., Stafford, M., Zheng, C. H. & Levenston, M. E. Variations in chondrogenesis of human bone marrow-derived mesenchymal stem cells in fibrin/alginate blended hydrogels. Acta Biomaterialia 8, 3754–3764, doi:10.1016/j.actbio.2012.06.028 (2012).

  40. 40.

    Schuurman, W. et al. Zonal Chondrocyte Subpopulations Reacquire Zone-Specific Characteristics During In Vitro Redifferentiation. American Journal of Sports Medicine 37, 97S–104S, doi:10.1177/0363546509350978 (2009).

  41. 41.

    Watts, A. E., Ackerman-Yost, J. C. & Nixon, A. J. A Comparison of Three-Dimensional Culture Systems to Evaluate In Vitro Chondrogenesis of Equine Bone Marrow-Derived Mesenchymal Stem Cells. Tissue Engineering Part A 19, 2275–2283, doi:10.1089/ten.tea.2012.0479 (2013).

  42. 42.

    Ekanayake, S. & Hall, B. K. Hypertrophy is not a prerequisite for type-x collagen expression or mineralization of chondrocytes derived from cultured chick mandibular ectomesenchyme. International Journal of Developmental Biology 38, 683–694 (1994).

  43. 43.

    Gerstenfeld, L. C. & Landis, W. J. Gene-expression and extracellular-matrix ultrastructure of a mineralizing chondrocyte cell-culture system. Journal of Cell Biology 112, 501–513, doi:10.1083/jcb.112.3.501 (1991).

  44. 44.

    Sullivan, T. A., Uschmann, B., Hough, R. & Leboy, P. S. Ascorbate modulation of chondrocyte gene-expression is independent of its role in collagen secretion. Journal of Biological Chemistry 269, 22500–22506 (1994).

  45. 45.

    Childs, A. C., Mehta, D. J. & Gerner, E. W. Polyamine-dependent gene expression. Cellular and Molecular Life Sciences 60, 1394–1406, doi:10.1007/s00018-003-2332-4 (2003).

  46. 46.

    Igarashi, K. & Kashiwagi, K. Modulation of cellular function by polyamines. The international journal of biochemistry & cell biology 42, 39–51 (2010).

  47. 47.

    Facchini, A. et al. Role of polyamines in hypertrophy and terminal differentiation of osteoarthritic chondrocytes. Amino Acids 42, 667–678, doi:10.1007/s00726-011-1041-9 (2012).

  48. 48.

    Mwale, F., Stachura, D., Roughley, P. & Antoniou, J. Limitations of using aggrecan and type X collagen as markers of chondrogenesis in mesenchymal stem cell differentiation. Journal of Orthopaedic Research 24, doi:10.1002/jor.20200 (2006).

  49. 49.

    Hwang, W. S. et al. Collagen fibril structure of normal, aging, and osteoarthritic cartilage. Journal of Pathology 167, 425–433, doi:10.1002/path.1711670413 (1992).

  50. 50.

    Wong, M. & Carter, D. R. Articular cartilage functional histomorphology and mechanobiology: a research perspective. Bone 33, doi:10.1016/s8756-3282(03)00083-8 (2003).

  51. 51.

    Schefe, J. H., Lehmann, K. E., Buschmann, I. R., Unger, T. & Funke-Kaiser, H. Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression’s C-T difference” formula. Journal of Molecular Medicine-Jmm 84, doi:10.1007/s00109-006-0097-6 (2006).

  52. 52.

    Creek, D. J., Jankevics, A., Burgess, K. E. V., Breitling, R. & Barrett, M. P. IDEOM: An Excel interface for analysis of LC-MS based metabolomics data. Bioinformatics, doi:10.1093/bioinformatics/bts069 (2012).

  53. 53.

    Scheltema, R. A., Jankevics, A., Jansen, R. C., Swertz, M. A. & Breitling, R. PeakML/mzMatch: A File Format, Java Library, R Library, and Tool-Chain for Mass Spectrometry Data Analysis. Analytical Chemistry 83, 2786–2793, doi:10.1021/ac2000994 (2011).

  54. 54.

    Compton, S. J. & Jones, C. G. Mechanism of dye response and interference in the bradford protein assay. Analytical Biochemistry 151, doi:10.1016/0003-2697(85)90190-3 (1985).

  55. 55.

    Creek, D. J. et al. Toward Global Metabolomics Analysis with Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry: Improved Metabolite Identification by Retention Time Prediction. Analytical Chemistry 83, 8703–8710, doi:10.1021/ac2021823 (2011).

  56. 56.

    Xia, J., Psychogios, N., Young, N. & Wishart, D. S. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Research 37, W652–W660, doi:10.1093/nar/gkp356 (2009).

Download references

Acknowledgements

This work was funded by the EPSRC DTC EP/F500424/1 and BBSRC grants BB/K006908/1 and BB/J018902/1. We thank Carol-Anne Smith for technical support.

Author information

Affiliations

  1. Institution for Integrative Medical Biology, Umeå University, SE901 87, Umeå, Sweden

    • Enateri V. Alakpa
  2. Centre for Cell Engineering, Institute of Molecular, Cell & Systems Biology, College of Medical, Veterinary & Life Sciences, Joseph Black Building, University of Glasgow, Glasgow, G12 8QQ, UK

    • Vineetha Jayawarna
    •  & Matthew J. Dalby
  3. Scottish Polyomics Facility, Wolfson Wohl Cancer Research Centre, College of Medical, Veterinary & Life Sciences, University of Glasgow, Garscube Estate, Glasgow, G61 1QH, UK

    • Karl E. V. Burgess
  4. Centre for Regenerative Medicine and Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4UU, UK

    • Christopher C. West
    •  & Bruno Péault
  5. Orthopaedic Surgery Dept and Broad Stem Cell Research Center, University of California, Los Angeles, USA

    • Bruno Péault
  6. Advanced Science Research Center (ASRC), University of New York, New York, NY, 10031, USA

    • Rein V. Ulijn

Authors

  1. Search for Enateri V. Alakpa in:

  2. Search for Vineetha Jayawarna in:

  3. Search for Karl E. V. Burgess in:

  4. Search for Christopher C. West in:

  5. Search for Bruno Péault in:

  6. Search for Rein V. Ulijn in:

  7. Search for Matthew J. Dalby in:

Contributions

Design and conceptualisation: M.J.D., R.V.U., B.P., K.V.B., and E.V.A. Methodology: V.J., R.V.U., E.V.A., M.J.D., K.V.B., B.P., and C.C.W. Investigation: E.V.A., V.J., K.V.B., and C.C.W. Manuscript text: E.V.A., V.J., M.J.D. and B.P. Manuscript Figures: E.V.A. and V.J. Review and edits: E.V.A., V.J., K.V.B., C.C.W., R.V.U., M.J.D. and B.P. Acquisition of funds: M.J.D., R.V.U. and B.P.

Competing Interests

RVU is CSO of Biogelx, a spinout company that markets the gels developed and used in this paper.

Corresponding author

Correspondence to Enateri V. Alakpa.

Electronic supplementary material

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Creative Commons BY

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.